ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024
WINSTON-SALEM, N.C., May 21, 2024 -- ProKidney Corp. , a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease , will host a virtual KOL event on Tuesday, May...
Source: marketscreener.com